XML 53 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1

Stockholders' Equity (Tables)

12 Months Ended

Aug. 31, 2017

Stockholders' Equity [Abstract]

Schedule Of Recognized Stock Based Compensation Expense [Table Text Block]

	The Company recognized stock-based compensation expense within selling, general and administrative expense as follows
(in thousands):
				Fiscal Year Ended August 31,
				2017			2016			2015
		Restricted stock and stock appreciation rights ("SARS")		$	42,122		$	52,459		$	58,033
		Employee stock purchase plan			6,334			6,538			4,717
		Other			88			―			(187)
			Total	$	48,544		$	58,997		$	62,563

Schedule Of Shares Available For Issuance [Table Text Block]

Following is a reconciliation of the shares available to be issued under the 2011 Plan as of August 31, 2017:

				Shares Available for Grant
Balance as of August 31, 2016				4,898,739
	Shares authorized (1)			4,950,000
	SARS canceled			1,357,386
	Restricted stock awards forfeited, net of grants(2)			1,022,811
Balance as of August 31, 2017				12,228,936
(1)	In January 2017, the Company’s stockholders approved increasing the maximum aggregate number of shares available for
	issuance under the 2011 Plan to 23,300,000.
(2)	Represents the maximum number of shares that can be issued based on the achievement of certain performance criteria.

Summary of Option Activity

The following table summarizes SARS activity from August 31, 2016 through August 31, 2017:

												Weighted-
									Weighted-			Average
						Average			Average			Remaining
				SARS		Intrinsic Value			Exercise			Contractual
				Outstanding		(in thousands)			Price			Life (years)
Outstanding as of August 31, 2016				2,439,066		$	1,066		$	25.32		1.13
	SARS canceled			(1,357,386)					$	29.15
	SARS exercised			(762,439)					$	20.78
Outstanding and exercisable as of August 31, 2017				319,241		$	3,651		$	19.91		2.10

Restricted Stock Activity

	The following table summarizes restricted stock activity from August 31, 2016 through August 31, 2017:
							Weighted-
							Average
							Grant-Date
					Shares		Fair Value
			Outstanding as of August 31, 2016		14,777,178		$	21.09
			Changes during the period
				Shares granted(1)	3,507,690		$	23.65
				Shares vested	(2,102,049)		$	20.94
				Shares forfeited	(4,530,500)		$	20.84
			Outstanding as of August 31, 2017		11,652,319		$	22.00
(1)	For those shares granted that are based on the achievement of certain performance criteria, the amount represents the maximum number of shares that can vest. During the fiscal year ended August 31, 2017, the Company awarded approximately 1.8 million time-based restricted stock units, 0.6 million performance-based restricted stock units and 0.4 million market-based restricted stock units based on target performance criteria.

Schedule Of Share Based Compensation Information [TableTextBlock]

	Following represents the restricted stock and SARS stock-based compensation information for the periods indicated (in thousands):
				Fiscal Year Ended August 31,
				2017			2016			2015
		Intrinsic value of SARS exercised		$	5,053		$	506		$	954
		Fair value of SARS vested		$	―		$	―		$	2,754
		Fair value of restricted stock vested		$	44,010		$	34,857		$	33,413
		Tax benefit (expense) for stock compensation expense(1)		$	560		$	991		$	(351)
		Capitalized stock compensation expense(2)		$	313		$	387		$	387
		Unrecognized stock-based compensation expense - restricted stock		$	45,158
		Remaining weighted-average period for restricted stock expense			1.4	years
(1)	Classified as income tax expense within the Consolidated Statements of Operations.
(2)	Classified as inventories within the Consolidated Balance Sheets.

Weighted Average Assumptions used in Black-Scholes Option Pricing Model

	The fair value of shares issued under the ESPP was estimated on the commencement date of each offering period using the
Black-Scholes option pricing model. The following weighted-average assumptions were used in the model for each respective period:
				Fiscal Year Ended August 31,
				2017			2016			2015
			Expected dividend yield	0.8	%		0.7	%		0.8	%
			Risk-free interest rate	0.5	%		0.3	%		0.1	%
			Expected volatility (1)	33.0	%		28.1	%		24.5	%
			Expected life	0.5 years			0.5 years			0.5 years
(1)	The expected volatility was estimated using the historical volatility derived from the Company's common stock.

Cash Dividends Declared to Common Stockholders

The following table sets forth certain information relating to the Company’s cash dividends declared to common stockholders during fiscal years 2017 and 2016:

							Total of Cash
		Dividend		Dividend			Dividends			Date of Record for		Dividend Cash
		Declaration Date		per Share			Declared			Dividend Payment		Payment Date
		(in thousands, except for per share data)
Fiscal year 2017:		October 20, 2016		$	0.08		$	15,248		November 15, 2016		December 1, 2016
		January 26, 2017		$	0.08		$	15,051		February 15, 2017		March 1, 2017
		April 20, 2017		$	0.08		$	14,840		May 15, 2017		June 1, 2017
		July 20, 2017		$	0.08		$	14,698		August 15, 2017		September 1, 2017
Fiscal year 2016:		October 14, 2015		$	0.08		$	15,906		November 16, 2015		December 1, 2015
		January 21, 2016		$	0.08		$	15,947		February 16, 2016		March 1, 2016
		April 21, 2016		$	0.08		$	15,940		May 16, 2016		June 1, 2016
		July 21, 2016		$	0.08		$	15,575		August 15, 2016		September 1, 2016

X

- Definition

Tabular disclosure of recognized stock-based compensation expense.

+ References

No definition available.

+ Details

Name:	jbl_ScheduleOfRecognizedShareBasedCompensationExpenseTableTextBlock
Namespace Prefix:	jbl_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of restricted stock and SARS stock-based compensation information, including but not limited to, intrinsic value, vested fair value, tax benefits for stock-based compensation expense, unrecognized stock-based compensation expense and remaining weighted-average period for restricted stock expense.

+ References

No definition available.

+ Details

Name:	jbl_ScheduleOfShareBasedCompensationInformationTableTextBlock
Namespace Prefix:	jbl_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of shares available for issuance under stock award and incentive plan.

+ References

No definition available.

+ Details

Name:	jbl_ScheduleOfSharesAvailableForIssuanceTableTextBlock
Namespace Prefix:	jbl_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.

+ References

No definition available.

+ Details

Name:	us-gaap_DividendsDeclaredTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration